| Full Name | Briana Broschat |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 161 Main St, Mission, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174243752 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | F08220646 (South Dakota) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 002530 (South Dakota) | Primary |
| Entity Name | Horizon Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356459382 PECOS PAC ID: 8921997933 Enrollment ID: O20040315000974 |
News Archive
Sanford Burnham Prebys Medical Discovery Institute has received an award from the California Institute for Regenerative Medicine to advance promising drug candidates for COVID-19.
XenoPort, Inc. announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented tomorrow at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan.
News-Medical speaks to Dr. Steven Stagg about his latest research into autism and how autistic children struggle to read hidden emotions.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by TAP Pharmaceuticals Inc. in connection with its Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets (lansoprazole), 15mg and 30mg.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Briana Broschat, Po Box 1552, Mission, SD 57555-1552 Ph: () - | Briana Broschat, 161 Main St, Mission, SD 57555 Ph: (856) 605-2295 |
News Archive
Sanford Burnham Prebys Medical Discovery Institute has received an award from the California Institute for Regenerative Medicine to advance promising drug candidates for COVID-19.
XenoPort, Inc. announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented tomorrow at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan.
News-Medical speaks to Dr. Steven Stagg about his latest research into autism and how autistic children struggle to read hidden emotions.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by TAP Pharmaceuticals Inc. in connection with its Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets (lansoprazole), 15mg and 30mg.
› Verified 1 days ago
Mrs. Autumn Rae Tucker, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 161 S, Main Street, Mission, SD 57555 Phone: 605-856-2295 | |
Ryan Ross Rowe, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 161 S. Main, Mission, SD 57555 Phone: 605-856-2295 | |
Alyssa Morgan Hicks, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 161 S Main Street, Mission, SD 57555 Phone: 605-856-2295 Fax: 866-423-6811 |